210 related articles for article (PubMed ID: 12165804)
1. Population-based screening for hereditary breast cancer in a region of North-Central Italy.
Casadei S; Falcini F; Naldoni C; Amadori D; Calistri D
Int J Mol Med; 2002 Sep; 10(3):299-305. PubMed ID: 12165804
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.
Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Scarpi E; Falcini F; Strada M; Morini N; Naldoni C; Amadori D; Calistri D
Breast Cancer Res Treat; 2008 Nov; 112(2):343-9. PubMed ID: 18092194
[TBL] [Abstract][Full Text] [Related]
4. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence in first-degree relatives of a population-based set of cases of early-onset breast cancer.
Rawal R; Bertelsen L; Olsen JH
Eur J Cancer; 2006 Nov; 42(17):3034-40. PubMed ID: 16996259
[TBL] [Abstract][Full Text] [Related]
8. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
[TBL] [Abstract][Full Text] [Related]
10. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk assessment: quality and impact of the family history interview.
Murff HJ; Byrne D; Syngal S
Am J Prev Med; 2004 Oct; 27(3):239-45. PubMed ID: 15450637
[TBL] [Abstract][Full Text] [Related]
12. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?
Brandt A; Lorenzo Bermejo J; Sundquist J; Hemminki K
Breast Cancer Res Treat; 2010 May; 121(1):133-41. PubMed ID: 19641988
[TBL] [Abstract][Full Text] [Related]
14. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
15. Notification of a family history of breast cancer: issues of privacy and confidentiality.
Winter PR; Wiesner GL; Finnegan J; Bartels D; LeRoy B; Chen PL; Sellers TA
Am J Med Genet; 1996 Dec; 66(1):1-6. PubMed ID: 8957501
[TBL] [Abstract][Full Text] [Related]
16. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
18. A scoring system for the strength of a family history of colorectal cancer.
Church JM
Dis Colon Rectum; 2005 May; 48(5):889-96. PubMed ID: 15785893
[TBL] [Abstract][Full Text] [Related]
19. Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases.
Albright LA; Schwab A; Camp NJ; Farnham JS; Thomas A
Prostate; 2005 Sep; 64(4):347-55. PubMed ID: 15754348
[TBL] [Abstract][Full Text] [Related]
20. Familial aggregation of breast cancer with early onset lung cancer.
Schwartz AG; Siegfried JM; Weiss L
Genet Epidemiol; 1999 Nov; 17(4):274-84. PubMed ID: 10520210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
